Resmed Inc. buy KeyCorp
Start price
26.04.24
/
50%
€190.40
Target price
26.04.25
€222.05
Performance (%)
10.61%
End price
27.04.25
€210.60
Summary
This prediction ended on 27.04.25 with a price of €210.60. The BUY prediction by KeyCorp finished with a performance of 10.61%. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.93 are taken into consideration when calculating the performance. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 1.541% | 1.541% | 3.681% |
| iShares Core DAX® | 4,85 % | -2,75 % | 13,10 % |
| iShares Nasdaq 100 | 4,00 % | -3,33 % | 31,34 % |
| iShares Nikkei 225® | 4,22 % | -2,91 % | 44,47 % |
| iShares S&P 500 | 3,32 % | -2,95 % | 24,36 % |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $227.00 to $238.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten